Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery

Intraoperative Ureter Injury Clinical Trial

Official title: A Phase 2 Open-label Study to Evaluate the Use of Nerindocianine as a Surgical Aid in the Delineation of Abdominopelvic Ureter Anatomy Via Near-infrared Fluorescence Imaging in the Setting of Minimally Invasive Surgery

Status Withdrawn

Clinical Trial Summary

Phase 2, multicenter, efficacy and safety study evaluating the use of nerindocianine for the delineation of abdominopelvic ureter anatomy via near infrared fluorescence imaging during minimally invasive lower abdominal surgery (e.g. gynecological, lower gastrointestinal, or other lower abdominal surgery).

Clinical Trial Description

The primary objective of this study is to assess the acceptance of near-infrared (NIR) fluorescence imaging (650 to 900 nm) compared to white light (WL) using 3 3-point Likert scales. ;

Related Conditions & MeSH terms

• Intraoperative Ureter Injury

• NCT number: NCT04636567
• Study type: Interventional
• Source: Li-Cor, Inc.
• Status: Withdrawn
• Phase: Phase 2
• Start date: March 2021
• Completion date: December 2021